Sudarshan Pharma Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sudarshan Pharma Industries Ltd. on BSE

Load latest

Sudarshan Pharma Industries Ltd.

29 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24A of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report issued by Mr. Vishal Manseta, Practicing Company Secretary for the financial year ended 31-March-2025.

pdf

Sudarshan Pharma Industries Ltd.

29 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulation 30(6) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, this is to inform you that the Company will be meeting Investors / Analysts on Tuesday, 03-June-2025. Kindly take the same on record.

pdf

Sudarshan Pharma Industries Ltd.

17 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisement - Notice of Extra Ordinary General Meeting to be held on 12th June, 2025

pdf

Sudarshan Pharma Industries Ltd.

16 May 2025

30.29

-1.97%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Extraordinary General Meeting On 12/June/2025

BSE India

Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find enclosed the Notice of Extraordinary General Meeting to be held on 12/June/2025 at 3.00 pm IST through video conferencing / other audio visual means.

pdf

Sudarshan Pharma Industries Ltd.

13 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of the Company''s submission dated 16th January 2025, this is to inform you that the Directors of the Company have at their meeting held on 13th May 2025 resolved to acquire 100% of the paid up share capital of CIbachem General Trading L. L. C. at a revised consideration of Rs.55 Lakhs or its equivalent foreign exchange.

pdf

Sudarshan Pharma Industries Ltd.

12 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

We are submitting the Company''s reply to queries raised by BSE Limited for the Corporate Announcement of the Company submitted on 2nd May 2025 pertaining to resignation of Mr. Sachin Mehta as Chief Financial Officer and appointment of Mr. Manoj Lodha as Chief Financial Officer of the Company, effective 1st May, 2025. Request you to take the same on record.

pdf

Sudarshan Pharma Industries Ltd.

02 May 2025

30.29

-1.97%

Investor Presentation

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

In terms of Regulation 30 read with Para A of Part A of Schedule III to SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor Presentation.

pdf

Sudarshan Pharma Industries Ltd.

02 May 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 01-May-2025, (i) Mr. Sachin Mehta is resigned as the Chief Financial Officer of the Company, he shall continue as the Joint Managing Director of the Company and (ii) Mr. Manoj Lodha has been appointed as the Chief Financial Officer of the Company.

pdf

Sudarshan Pharma Industries Ltd.

26 Apr 2025

30.29

-1.97%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed the newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the half year and financial year ended 31st March 2025 published in Mumbai Lakhsdeep (Marathi) and Financial Express (English).

pdf

Sudarshan Pharma Industries Ltd.

24 Apr 2025

30.29

-1.97%

Result

Sudarshan Pharma Industries Ltd - 543828 - Financial Results For The Financial Year Ended March 31, …

BSE India

Please find attached the Audited Standalone and Consolidated Financial Results for the financial year ended March 31, 2025

pdf